Recent SPRB News
- Spruce Biosciences to Participate in May Investor Conferences • Business Wire • 05/01/2024 08:05:00 PM
- Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting • Business Wire • 04/30/2024 08:05:00 PM
- Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting • Business Wire • 04/22/2024 08:05:00 PM
- Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates • Business Wire • 03/13/2024 08:08:00 PM
- Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH • Business Wire • 03/13/2024 08:01:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 09:07:56 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 09:15:16 PM
- Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • Business Wire • 01/30/2024 09:05:00 PM
- Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia • Business Wire • 01/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:00:10 PM
- Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH • Business Wire • 01/05/2024 01:00:00 PM
- Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024 • Business Wire • 01/04/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:10:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 01:17:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 01:15:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 12:00:09 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:22:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:09:31 PM
- Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates • Business Wire • 11/13/2023 09:05:00 PM
- Spruce Biosciences to Participate in the Jefferies London Healthcare Conference • Business Wire • 11/02/2023 08:05:00 PM
- Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia • Business Wire • 10/18/2023 12:00:00 PM
- Spruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference • Business Wire • 08/28/2023 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:20:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:12:57 PM
- Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates • Business Wire • 08/14/2023 08:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM